Sino Biological,Inc. (SHE:301047)

China flag China · Delayed Price · Currency is CNY
71.17
-0.13 (-0.18%)
At close: Mar 9, 2026
10.12%
Market Cap 8.66B
Revenue (ttm) 660.17M
Net Income (ttm) 132.79M
Shares Out 121.64M
EPS (ttm) 1.08
PE Ratio 66.20
Forward PE 59.81
Dividend 4.00 (5.61%)
Ex-Dividend Date Sep 22, 2025
Volume 933,380
Average Volume 796,436
Open 70.51
Previous Close 71.30
Day's Range 70.17 - 71.58
52-Week Range 57.40 - 85.00
Beta 1.02
RSI 42.87
Earnings Date Apr 14, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 1,021
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301047
Full Company Profile

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.

Financial Statements

News

There is no news available yet.